Genetic Testing for Breast & Ovarian

Suitable for high-risk individuals with family history.

SEP-PRO-BRCA1/2+24

$3,800

Working Hours

Monday to Friday:9 am – 6 pm
Saturday:9 am – 1 pm
Sunday and Public Holiday:Closed

eHealth System & Health Care Voucher

We can upload images to eHRSS.
We support the use of Health Care Voucher.

More Information
Why check for Hereditary Cancers?
Details

Genetic testing to identify hereditary cancers allows you to prevent and manage your health early.

Hereditary cancers account for approximately 5-10% of all cancers, and people who inherit genetic mutations generally are more likely to develop certain cancers at earlier age of onset than the common population.

Comprehensive

Convenient
only 5mL blood

Accurate
99.9% accuracy with alternative validation

Gene Tested:
BRCA1, BRCA2, CHEK2, PALB2, BRIP1, TP53, PTEN, STK11, CDH1, ATM, BARD1, MLH1,MRE11A, MSH2, MSH6, MUTYH, NBN,
PMS1, PMS2, RAD50, RAD51C, RAD51D, NF1, EPCAM, SMARCA4, CDK12

Common hereditary cancers (ranked by the total number of cancer deaths in 2018):

  • Breast cancer (626679, No. 5)
  • Ovarian cancer (184799, No. 14)
  • Uterine body cancer (endometrial cancer) (89929, 20th place)

Who should take Hereditary Cancer Tests?

  • Personal or family medical history characteristics, especially if they meet more than one of the following, the body may have hereditary cancer genes:
  • Two or more family members have breast cancer or ovarian cancer
  • Early-onset breast cancer was diagnosed in the family (under 45 years old)
  • The same person in the family has multiple breast cancers, or has breast cancer and ovarian cancer successively
  • A male in the family is a breast cancer patient
  • Patients with breast cancer or ovarian inflammation

Cancer associated with BRCA1 mutation (lifetime risk)
Details

Breast cancer 50%-85% (with early age of onset)

Breast cancer 40%-60% ( breast cancer on other side of the breast)

Ovarian cancer 15%-45%

There is a high risk of other cancers (e.g. colon cancer)

Cancer associated with BRCA2 mutation (lifetime risk)
Details

Female:

Breast cancer 50%-85% with early age of onset

Ovarian cancer 10%-20%